Username Password
S&P 500: 1,351.68 Change: +0.14%
Pegger
Pegger
P&P Score: 23.13
Stats
Pegger IS BEATING THE MARKET TODAY
Points: 4.83 (+0.00)
Accuracy: 14.29%
Annual Return: 3.50% 
(11.85% since 9/25/08)
Average Pick Score: -29.60
About Me
Real name Pegger
Favorites
Pegger has no favorites
Groups
Pegger has no groups
Highlighted Picks
Most Recent  02/11/10
BUY    MCRL   $11.52
MICREL INCORPORATED   -0.43%
President/ CEO bought 40K shares on Feb 8 & 9th , dividend 1.9 % Zack rates buy. Bougth today at 7.79 and placed trailing stop at 7% -will sell on sto…more
Most Successful  02/11/10
BUY    MCRL   $11.52
MICREL INCORPORATED   +17.59%
President/ CEO bought 40K shares on Feb 8 & 9th , dividend 1.9 % Zack rates buy.…more
Least Successful  09/24/08
BUY    BSDM   $2.22
BSD MED CORP DEL   -78.23%
Research trials very positive
Recent Posts
Most Recent Blog Post
Pegger has no blog posts
Most Recent Comments

Pegger has no recent comments

Picks

Open
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
02/11/2010 MCRL Rating: 4 BUY One to Three Months $8.06 $11.52
(-0.43%)
- +42.93% +25.33% +17.59 view
02/06/2010 CL Rating: 4 BUY One to Three Years $79.26 $91.73
(+0.35%)
- +15.73% +26.78% -11.04 view
10/17/2008 QGEN Rating: 3 BUY One to Three Years $15.87 $15.55
(-0.73%)
- -2.01% +43.71% -45.72
10/17/2008 XLV Rating: 3 BUY Week or Less $27.15 $35.99
(-0.42%)
- +32.56% +43.71% -11.15 view
10/16/2008 CSCO Rating: 2 BUY Six Months to a Year $17.75 $20.02
(-1.60%)
- +12.76% +42.82% -30.06 view
09/30/2008 FLIR Rating: 3 BUY Three to Six Months $38.42 $25.86
(+1.31%)
- -32.68% +15.89% -48.57 view
09/24/2008 BSDM Rating: 0 BUY One to Three Years $6.21 $2.22
(+1.37%)
- -64.25% +13.98% -78.23 view
Closed
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
All
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
02/11/2010 MCRL Rating: 4 BUY One to Three Months $8.06 $11.52
(-0.43%)
- +42.93% +25.33% +17.59 view
02/06/2010 CL Rating: 4 BUY One to Three Years $79.26 $91.73
(+0.35%)
- +15.73% +26.78% -11.04 view
10/17/2008 QGEN Rating: 3 BUY One to Three Years $15.87 $15.55
(-0.73%)
- -2.01% +43.71% -45.72
10/17/2008 XLV Rating: 3 BUY Week or Less $27.15 $35.99
(-0.42%)
- +32.56% +43.71% -11.15 view
10/16/2008 CSCO Rating: 2 BUY Six Months to a Year $17.75 $20.02
(-1.60%)
- +12.76% +42.82% -30.06 view
09/30/2008 FLIR Rating: 3 BUY Three to Six Months $38.42 $25.86
(+1.31%)
- -32.68% +15.89% -48.57 view
09/24/2008 BSDM Rating: 0 BUY One to Three Years $6.21 $2.22
(+1.37%)
- -64.25% +13.98% -78.23 view
Commentary
BUY: MICREL INCORPORATED (MCRL) Rating: 4
Start Price: $8.06
Points: +17.59
Created: 02/11/2010
President/ CEO bought 40K shares on Feb 8 & 9th , dividend 1.9 % Zack rates buy. Bougth today at 7.79 and placed trailing stop at 7% -will sell on stop if not before.

Comments: 0 | Comment

Recs:
 
BUY: COLGATE PALMOLIVE (CL) Rating: 4
Start Price: $79.26
Points: -11.04
Created: 02/06/2010
EPS Growth 19.40% PE 18 PEG <1 Div 2.68% No Debt Beta .51 Fairly solid company

Comments: 0 | Comment

Recs:
 
BUY: QIAGEN N.V. - COMMON SHARES (QGEN) Rating: 3
Start Price: $15.87
Points: -45.72
Created: 10/17/2008

Comments: 0 | Comment

Recs:
 
BUY: SELECT SECTOR SPDR-HEALTH CARE (XLV) Rating: 3
Start Price: $27.15
Points: -11.15
Created: 10/17/2008
good health companies in this ETF. Will always need medical services and products, good entry point

Comments: 0 | Comment

Recs:
 
BUY: CISCO SYSTEMS INC. (CSCO) Rating: 2
Start Price: $17.75
Points: -30.06
Created: 10/16/2008
cheap peg, high margin, new system coming,great cash flow

Comments: 0 | Comment

Recs:
 
BUY: FLIR SYSTEMS INC. (FLIR) Rating: 3
Start Price: $38.42
Points: -48.57
Created: 09/30/2008
Good fundamentals, held up well with recent failed bailout , great earnings

Comments: 0 | Comment

Recs:
 
BUY: BSD MED CORP DEL (BSDM)
Start Price: $6.21
Points: -78.23
Created: 09/24/2008
Research trials very positive

Comments: 0 | Comment

Recs:
 
Sponsored Links

Free Options Trader Guide